指南与共识心脑血管急症

探索即刻使用抗癫痫发作药物的推荐建议:地西泮鼻喷雾剂同时治疗丛集性发作与持续性发作

Exploring proposed recommendations for immediate-use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal spray.
指南 / 共识 · Epilepsia Open · 2025-05-10
一句话结论长期安全性研究显示地西泮鼻喷雾剂单次给药可终止87.4%的丛集性发作,且67.3%的发作在5分钟内被识别并治疗,支持其作为急性丛集治疗(ACT)和快速早期终止发作(REST)的即刻用药。

癫痫终止项目(Seizure Termination Project)制定了关于丛集性发作和持续性发作门诊管理的专家共识推荐,提出急性丛集治疗(ACT)和快速早期癫痫终止(REST)两个治疗场景。本文利用地西泮鼻喷雾剂长期安全性研究的患者水平数据,检验ACT和REST标准。结果显示,单次给药在24小时内有效终止绝大多数丛集性发作(3368/3853,87.4%),且多数发作在起病5分钟内被识别并治疗(2169/3225,67.3%),在发作变为持续性后治疗仍保持有效性。这些发现支持地西泮鼻喷雾剂用于急性发作和丛集内持续性发作的即刻治疗,与近期专家共识推荐一致,早期使用单次急救治疗可满足ACT和REST需求,简化患者护理。

要点

  • 地西泮鼻喷雾剂单次给药在24小时内终止87.4%(3368/3853)的丛集性发作,支持其作为急性丛集治疗(ACT)。
  • 67.3%(2169/3225)的丛集性发作在起病5分钟内被识别并治疗,支持其作为快速早期癫痫终止(REST)。
  • 在发作已变为持续性(分析中定义为5-15分钟)后给药,有效性仍维持。
  • 早期使用单次急救治疗即可同时满足ACT和REST需求,可能简化患者护理。

适用人群与场景

  • 丛集性发作患者,数据来自地西泮鼻喷雾剂长期安全性研究。
  • 门诊场景下由患者或照护者使用,用于急性丛集治疗(ACT)和快速早期癫痫终止(REST)。

诊断标准与关键阈值

  • 急性丛集治疗(ACT):用于预防丛集内进一步发作的急性丛集治疗。
  • 快速早期癫痫终止(REST):用于终止预期会变为持续性的正在进行的发作。
  • 本分析中持续性发作定义为丛集内发作持续5-15分钟。

处置流程与药物剂量

  • 地西泮鼻喷雾剂单次给药用于丛集性发作的即刻治疗。

研究设计与关键结果

  • 研究类型为地西泮鼻喷雾剂长期安全性研究的患者水平数据分析,评估丛集性发作。
  • 单次给药在24小时内有效终止大多数丛集性发作:3368/3853(87.4%)。
  • 多数丛集性发作在起病5分钟内被识别并治疗:2169/3225(67.3%)。
  • 在发作已变为持续性(5-15分钟)后给药,有效性仍维持。
  • 单次给药作为ACT和REST均显示获益,支持近期专家共识推荐。

证据类型、等级与局限

  • 证据类型:基于地西泮鼻喷雾剂长期安全性研究数据的分析,属于专家共识推荐的实践应用探索。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 早期使用单次地西泮鼻喷雾剂急救治疗可同时满足ACT和REST需求,可能简化患者护理。
  • 作者认为这些发现支持地西泮鼻喷雾剂用于急性发作和丛集内持续性发作的即刻治疗,与近期专家共识推荐一致。

指南或共识出处

  • 癫痫终止项目(Seizure Termination Project)专家共识推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The Seizure Termination Project developed expert consensus recommendations for outpatient management of seizure clusters and prolonged seizures to prevent progression to a higher-level emergency. The consensus recommendations described therapeutic scenarios for seizure clusters (acute cluster treatment [ACT]) to prevent further seizures in a cluster and treatment to stop ongoing seizures that were expected to be prolonged (rapid and early seizure termination [REST]). Here, we review ACT and REST as categories and explore their practical application by examining patient-level data for diazepam nasal spray. ACT and REST criteria were examined using data from the long-term safety study that evaluated diazepam nasal spray for seizure clusters. To explore the effectiveness and duration of treatment for ACT, the proportion of seizure clusters for which second doses were administered within 24 h was used as a proxy. REST was investigated using the time from administration to seizure cluster termination; timing for the termination of prolonged seizures (5-15 min for the purposes of this analysis) in clusters also was examined. In the long-term safety study of diazepam nasal spray, a single dose demonstrated effectiveness at terminating a substantial majority of seizure clusters (3368/3853 [87.4%]) across 24 h, demonstrating its use as ACT. The majority of seizure clusters (2169/3225 [67.3%]) were recognized and treated quickly, within 5 min from onset, demonstrating its utility as REST. Notably, effectiveness was maintained in seizures treated after they had become prolonged. These findings from the large dataset of the long-term safety study of diazepam nasal spray demonstrate that it is of benefit in immediate use for both termination of an acute seizure and prolonged seizures within seizure clusters, thus supporting the recent expert consensus recommendations. Early use of a single rescue treatment can meet the need for ACT and REST, simplifying patient care. PLAIN LANGUAGE SUMMARY: An expert group defined 2 groups of seizure medicines for patients and caregivers to use. "ACT" medicines are for acute cluster treatment to prevent more seizures in a cluster. "REST" medicines for rapid and early seizure treatment stop prolonged seizures. Diazepam nasal spray for seizure clusters was looked at to see if it could fit in both categories. Study data showed that for most seizure clusters only 1 dose of diazepam nasal spray was used over 24 h (fitting ACT), and seizures were treated and ended quickly (fitting REST). One medicine for REST and ACT may make treatment simpler.

来源:Epilepsia Open,查看原文。版权归原作者所有。

参考来源

  1. Chez M, Klein P, Becker D, et al. Exploring proposed recommendations for immediate-use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal spray. Epilepsia Open. 2025. PMID: 40347447. doi:10.1002/epi4.70054

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。